Herantis Pharma nominated new Board Directors

Herantis Pharma Plc
Release 29 April 2014 at noon.

Helsinki 29 April 2014 – Herantis Pharma Plc announced today that its extraordinary general meeting nominated three new members in its Board of Directors while three existing Board members continue in their role. Aki Prihti, Jim Phillips and Frans Wuite, previous non-executive directors at Laurantis Pharma were nominated to the board of directors at Herantis Pharma Plc. Pekka Mattila who was nominated the chairman of the board at Herantis Pharma Plc as well as Jonathan Knowles and Timo Veromaa continue as members of the board of Herantis Pharma Plc.

Herantis Pharma Plc
Board of directors

Further information:

Herantis Pharma Plc, Pekka Simula, Managing Director, mobile: +358 40 7300 445

Herantis Pharma Plc

Herantis Pharma Plc is a pharmaceutical company specialising in introducing early stage clinical research results for the purposes of clinical research aiming at developing new drugs. The company focuses on diseases for which treatment is not known or known treatments are insufficient. These diseases include for example dry eye syndrome, Parkinson’s disease, and secondary lymphedema.